185 related articles for article (PubMed ID: 9111873)
21. A multicenter trial of specific local nasal immunotherapy.
Motta G; Passali D; De Vincentiis I; Ottaviani A; Maurizi M; Sartoris A; Pallestrini E; Motta S; Salzano FA
Laryngoscope; 2000 Jan; 110(1):132-9. PubMed ID: 10646729
[TBL] [Abstract][Full Text] [Related]
22. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
Tahamiler R; Saritzali G; Canakcioglu S
Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861
[TBL] [Abstract][Full Text] [Related]
23. Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule.
Colás C; Monzón S; Venturini M; Lezaun A
J Allergy Clin Immunol; 2006 Apr; 117(4):810-6. PubMed ID: 16630938
[TBL] [Abstract][Full Text] [Related]
24. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen.
Rolinck-Werninghaus C; Wolf H; Liebke C; Baars JC; Lange J; Kopp MV; Hammermann J; Leupold W; Bartels P; Gruebl A; Bauer CP; Schnitker J; Wahn U; Niggemann B
Allergy; 2004 Dec; 59(12):1285-93. PubMed ID: 15507097
[TBL] [Abstract][Full Text] [Related]
25. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract.
Enrique E; Pineda F; Malek T; Bartra J; Basagaña M; Tella R; Castelló JV; Alonso R; de Mateo JA; Cerdá-Trias T; San Miguel-Moncín Mdel M; Monzón S; García M; Palacios R; Cisteró-Bahíma A
J Allergy Clin Immunol; 2005 Nov; 116(5):1073-9. PubMed ID: 16275379
[TBL] [Abstract][Full Text] [Related]
26. Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment.
Subiza J; Feliú A; Subiza JL; Uhlig J; Fernández-Caldas E
Clin Exp Allergy; 2008 Jun; 38(6):987-94. PubMed ID: 18445082
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ
J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
[TBL] [Abstract][Full Text] [Related]
28. Baseline serum tryptase levels and adverse reactions to injection specific immunotherapy with airborne allergens: is there a relationship?
Asero R; Farioli L; Pastorello EA
Int Arch Allergy Immunol; 2012; 158(3):276-80. PubMed ID: 22398453
[TBL] [Abstract][Full Text] [Related]
29. [Apropos of sublingual specific immunotherapy].
Sabbah A
Allerg Immunol (Paris); 1998 Apr; 30(4):97-8. PubMed ID: 9631689
[No Abstract] [Full Text] [Related]
30. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis.
Smith H; White P; Annila I; Poole J; Andre C; Frew A
J Allergy Clin Immunol; 2004 Oct; 114(4):831-7. PubMed ID: 15480323
[TBL] [Abstract][Full Text] [Related]
31. [Sublingual vs subcutaneous immunotherapy].
Olivé Pérez A
Rev Alerg Mex; 2004; 51(1):29-35. PubMed ID: 15119753
[TBL] [Abstract][Full Text] [Related]
32. [Allergen-specific immunotherapy].
Hansen TK; Svendsen UG
Ugeskr Laeger; 2005 Feb; 167(6):666-71. PubMed ID: 15771384
[No Abstract] [Full Text] [Related]
33. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
34. Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage.
Durham SR; Riis B
Allergy; 2007 Aug; 62(8):954-7. PubMed ID: 17620075
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
[TBL] [Abstract][Full Text] [Related]
36. Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites.
Passalacqua G; Pasquali M; Ariano R; Lombardi C; Giardini A; Baiardini I; Majani G; Falagiani P; Bruno M; Canonica GW
Allergy; 2006 Jul; 61(7):849-54. PubMed ID: 16792583
[TBL] [Abstract][Full Text] [Related]
37. Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care.
Röder E; Berger MY; Hop WC; Bernsen RM; de Groot H; Gerth van Wijk R
J Allergy Clin Immunol; 2007 Apr; 119(4):892-8. PubMed ID: 17321581
[TBL] [Abstract][Full Text] [Related]
38. Sublingual immunotherapy with a latex extract in paediatric patients: a double-blind, placebo-controlled study.
Bernardini R; Campodonico P; Burastero S; Azzari C; Novembre E; Pucci N; Massai C; De Martino M; Vierucci A
Curr Med Res Opin; 2006 Aug; 22(8):1515-22. PubMed ID: 16870076
[TBL] [Abstract][Full Text] [Related]
39. Respiratory allergy to the pollen of Mercurialis annua (Euphorbiaceae).
Ariano R; Panzani RC; Falagiani P; Chiapella M; Augeri G
Ann Allergy; 1993 Mar; 70(3):249-54. PubMed ID: 8452320
[TBL] [Abstract][Full Text] [Related]
40. Increase of respiratory allergy to the pollens of cypresses in the south of France.
Panzani R; Centanni G; Brunel M
Ann Allergy; 1986 Jun; 56(6):460-3. PubMed ID: 3717712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
